Potential difference measurements in the lower airway of children with and without cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 171, Issue 9, 2005, Pages 1015-1019

  Davies, Jane C ^a   Davies, Michael ^b   McShane, Donna ^b   Smith, Stephen ^b   Chadwick, Sharon ^b   Jaffe, Adam ^b   Farley, Raymond ^b   Collins, Louise ^b   Bush, Andrew ^b   Scallon, Michael ^b   Pepper, John ^b   Geddes, Duncan M ^b   Alton, Eric W F W ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

Cystic fibrosis; Ion transport; Potential difference

Indexed keywords

CHLORIDE; ISOPRENALINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BRONCHOSCOPE; CATHETERIZATION; CFTR GENE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE; HUMAN; ION TRANSPORT; LOWER RESPIRATORY TRACT; PRIORITY JOURNAL;

BRONCHI; BRONCHOSCOPY; CATHETERIZATION; CHILD; CHILD, PRESCHOOL; CHLORIDES; CYSTIC FIBROSIS; HUMANS; INFANT; ION TRANSPORT; MEMBRANE POTENTIALS; TRACHEA;

EID: 20944434002     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200408-1116OC     Document Type: Article

References (20)

1. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-1254.
2. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, Boucher RC. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998;95:1005-1015.
3. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 1995;310:1571-1572.
4. CF Foundation. Patient Registry 1994 Annual Data Report, CF Foundation. Bethesda, MD: CF Foundation; 1995.
5. Davies JC, Geddes DM, Alton EW. Gene therapy for cystic fibrosis. J Gene Med 2001;3:409-417.
6. Lim M, Zeitlin PL. Therapeutic strategies to correct malfunction of CFTR. Paediatr Respir Rev 2001;2:159-164.
7. Knowles M, Gatzy J, Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 1981;305:1489-1495.
8. Middleton PG, Geddes DM, Alton EWFW. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium. Eur Respir J 1994;7:2050-2056.
9. Wilson DC, Ellis L, Zielenski J, Corey M, Ip WF, Tsui LC, Tullis E, Knowles MR, Durie PR. Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr 1998;132:596-599.
10. Delmarco A, Pradal U, Cabrini G, Bonizzato A, Mastella G. Nasal potential difference in cystic fibrosis patients presenting borderline sweat test. Eur Respir J 1997;10:1145-1149.
11. Caplen NJ, Alton EW, Middleton PG, Dorin JR, Stevenson BJ, Gao X, Durham SR, Jeffery PK, Hodson ME, Coutelle C, et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1995:1:39-46.
12. Wilschanski M, Famini C, Blau H, Rivlin J, Augarten A, Avital A, Kerem B, Kerem E. A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations. Am J Respir Crit Care Med 2000;161:860-865.
13. Rubenstein RC, Zeitlin PL. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am J Respir Crit Care Med 1998;157:484-490.
14. Alton EW, Stern M, Parley R, Jaffe A, Chadwick SL, Phillips J, Davies J, Smith SN, Browning J, Davies MG, et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 1999;353:947-954.
15. Davies JC, Davies MG, Smith S, Jaffe A, Bush A, Scallon M, Geddes DM, Alton EW. Confirmation of abnormal chloride ion secretion in the lower airway of children with cystic fibrosis. Pediatr Pulmonol 2000;S20:293.
16. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM. Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 1994;93:737-749.
17. Porteous DJ, Dorin JR, McLachlan G, Davidson-Smith H, Davidson H, Stevenson BJ, Carothers AD, Wallace WA, Moralee S, Hoenes C, et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to nasal epithelium of patients with cystic fibrosis. Gene Ther 1997;4:210-218.
18. Hyde SC, Southern KW, Gileadi U, Fitzjohn EM, Mofford KA, Waddell BE, Gooi HC, Goddard CA, Hannavy K, Smyth SE, et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 2000;7:1156-1165.
19. Johnson LG, Boyles SE, Wilson J, Boucher RC. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J Clin Invest 1995;95:1377-1382.
20. Davies J, Payne D. Research applications of bronchoscopy. Paediatr Respir Rev 2003;4:230-236.